Log in
Browse
Membranes
Methods
Transporters
Sets
Search
Statistics
Lab
Documentation

Pentobarbital

2D Structure
3D Structure
Source:
General
Identifier MM470871
SMILES CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
InChIKey WEXRUCMBJFQVBZ-UHFFFAOYSA-N
MW [Da] 226.28

Automatically obtained from RDkit software.
LogP 1.19

Automatically obtained from RDkit software.
Links

PubChem

 N/A

DrugBank

 N/A

ChEBI

 N/A

PDB

 N/A

ChEMBL

 N/A
Similar entries
5-butyl-5-ethyl-1,3-diazinane-2,4,6-trione
Similarity: 0.8844
Similarity to 5-butyl-5-ethyl-1,3-diazinane-2,4,6-trione
Tanimoto metric 0.8844
Cosine metric 0.9404
Dice metric 0.9387
MW:
212.25
PI:
5
Total passive interactions
Pentobarbital
 0
5-butyl-5-ethyl-1,3-diazinane-2,4,6-trione
 5
LogP:
0.94
AI:
0
Total active interactions
Pentobarbital
 1
5-butyl-5-ethyl-1,3-diazinane-2,4,6-trione
 0
5-ethyl-5-(3-methylbutyl)-1,3-diazinane-2,4,6-trione
Similarity: 0.867
Similarity to 5-ethyl-5-(3-methylbutyl)-1,3-diazinane-2,4,6-trione
Tanimoto metric 0.867
Cosine metric 0.9299
Dice metric 0.9288
MW:
226.28
PI:
7
Total passive interactions
Pentobarbital
 0
5-ethyl-5-(3-methylbutyl)-1,3-diazinane-2,4,6-trione
 7
LogP:
1.19
AI:
0
Total active interactions
Pentobarbital
 1
5-ethyl-5-(3-methylbutyl)-1,3-diazinane-2,4,6-trione
 0
5,5-diethyl-1,3-diazinane-2,4,6-trione
Similarity: 0.7337
Similarity to 5,5-diethyl-1,3-diazinane-2,4,6-trione
Tanimoto metric 0.7337
Cosine metric 0.8565
Dice metric 0.8464
MW:
184.2
PI:
7
Total passive interactions
Pentobarbital
 0
5,5-diethyl-1,3-diazinane-2,4,6-trione
 7
LogP:
0.16
AI:
0
Total active interactions
Pentobarbital
 1
5,5-diethyl-1,3-diazinane-2,4,6-trione
 0
+2 more

No data

Hide empty columns:
Target
Uniprot ID
Type
pKm
pEC50
pKi
pIC50
Primary
reference
Secondary
reference
Note
CACNA1F
Non-inhibitor
3.52

Kowalska M, Nowaczyk J, Nowaczyk A.: KV11.1, NaV1.5, and CaV1.2 Transporter Proteins as Antitarget for Drug Cardiotoxicity. Int J Mol Sci, Volume 21 (21), 2020

Kowalska M, Nowaczyk J, Nowaczyk A.: KV11.1, NaV1.5, and CaV1.2 Transporter Proteins as Antitarget for Drug Cardiotoxicity. Int J Mol Sci, Volume 21 (21), 2020

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR.: The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res, Volume 52 (d1), D1180-D1192, 2024

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR.: The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res, Volume 52 (d1), D1180-D1192, 2024